New York, United States
Lokavant, founded in 2020, is at the forefront of clinical intelligence, focused on enhancing trial execution through its innovative data-driven analytics platform. With a slogan that signifies its transformative approach—"A Paradigm Shift in Clinical Trial Intelligence"—Lokavant empowers study teams by aggregating and integrating real-time data from a variety of trial data sources.
Headquartered in the United States, Lokavant operates within the AI and Data Analytics industries. Their platform leverages advanced analytics to streamline processes through risk-based monitoring, study health tracking, trial planning, benchmarking, and medical monitoring. This ability to surface insights and drive operational efficiency positions Lokavant as a valuable player in today’s competitive healthcare market.
Recently, on 03 October 2023, Lokavant secured an $8.00M Series A investment from Mitsui & Co, a vote of confidence in its potential to redefine clinical trial management.
